
|Articles|December 15, 2003
B&L wins FDA review, kicks off celebration
Rochester, NY-Bausch &Lomb is looking to the future and the past as it celebrates the FDA acceptance of a new drug application for its new anti-inflammatory/antibiotic combination product while marking the company's 150 years in business.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
Neurotrophic keratitis outcomes improve with early, stage-based care
3
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
4
Alcon raises offer in amended deal to acquire STAAR Surgical
5












































.png)


